Lupin Limited has informed the Exchange regarding a press release dated July 01, 2025, titled "Lupin Receives Approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Gel".
Lupin Limited has informed the Exchange regarding a press release dated July 01, 2025, titled "Lupin Receives Approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Gel".